- Nearly 1 in 7 patients hospitalized for IBD are readmitted within 30 days of the initial discharge.
Why this matters
- Hospital care accounts for up to one-third of the IBD management costs.
- Researchers studied the health records of patients admitted to hospitals in 2 states (New York, 19,559 patients; Florida, 19,676 patients) for IBD treatment to determine the prevalence of 30-day IBD-specific readmission.
- Funding: None.
- 13.7%-16.2% of the IBD-related stays resulted in a 30-day readmission.
- 30-day readmissions were associated with a longer length of stay than index hospitalizations by 1.00 day (adjusted regression coefficient, 1.00; 95% CI, 0.73-1.26).
- They also were associated with a higher likelihood of having a comorbid condition:
- New York: aOR, 1.83; 95% CI, 1.68-1.99.
- Florida: aOR, 1.79; 95% CI, 1.64-1.95.
- The study was retrospective, subject to misclassification bias, and did not assess causality.